MedAssets Awards Catheter Connections a Contract to Provide the DualCap® Technology to Healthcare Providers Nationwide

Share Article

Innovative Technology Saves Lives and Key to Reducing Infections and Improving Overall Patient Care

Catheter Connections, originator of the DualCap System™, is proud to have been awarded a GPO contract by MedAssets. The DualCap System will provide MedAssets’ 4400+ healthcare facilities across the nation easy access to DualCap, giving them a tool to save lives and greatly reduce hospital-acquired conditions, particularly catheter related bloodstream infections (CRBSI)

DualCap is the first FDA cleared and patented disinfection cap that safely disinfects and protects male luer connectors as well as needleless connectors. DualCap’s unique technology safely disinfects the male luer without getting any toxic isopropyl alcohol into the patient’s infusion line. It is the only medical device on the market that meets these important safety criteria. DualCap provides a simple solution to a common and expensive problem - CRBSI, which can cost providers thousands for each occurrence

The partnership comes at a critical time for health care providers, as over 750 hospitals are set to face fines for hospital-acquired conditions, including CRBSI. The fines, mandated by the Affordable Care Act, reportedly total more than $300 million and are triggered in large part by CRBSI.

“Our partnership with MedAssets is an important step forward in our strategic growth, and is validation that the DualCap System provides a simple, affordable answer to a very costly problem,” says Catheter Connections Founder and President Vicki Farrar . “This partnership and the exploding demand for DualCap is exciting – it shows that the industry is now ready to step forward and help reduce unnecessary CRBSI.”

Disinfection caps are quickly becoming a standard in health care, and are now included in the official practice recommendations set forth by the Society for Healthcare Epidemiology of America and the Infectious Diseases Society of America. Importantly, practice criteria set forth by the Infusion Nursing Society states that male luer connectors be covered with sterile devices after each intermittent use.

To learn more about the DualCap System, please visit

About MedAssets
MedAssets is a healthcare performance improvement company focused on helping providers realize financial and operational gains so that they can sustainably serve the needs of their community. More than 4,400 hospitals and 122,000 non-acute healthcare providers currently use the company's evidence-based solutions, best practice processes and analytics to help reduce the total cost of care, enhance operational efficiency, align clinical delivery, and improve revenue performance across the care continuum. For more information, please visit

About Catheter Connections
Headquartered in Salt Lake City, Utah, Catheter Connections, Inc., develops and commercializes innovative infection control products designed to protect patients from acquiring infections during intravenous infusion therapy. Its DualCap System™ is a family of user-friendly products that provides healthcare facilities with a cost-effective, integrated solution for IV disinfection and protection, helping in the fight against catheter-related blood stream infections. Designed by nurses for nurses, flagship product DualCap safely disinfects IV needleless connectors and male luers— a major breakthrough for infection control. For more information, visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jennifer R. Hoglin, Vice President of Marketing